Fund shareholders of Minerva Neurosciences Inc
ISIN US6033802058 · United States · LEI 54930017PANCHC5LYH79
- Fund shareholders
- 12
- Of which ETFs
- 0 12 other funds
- Value held
- 15M $
- Share of capital
- 5.1 % of 47.7M shares on Aug 4, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,319,143 | 7.9M $ | 0.00 % | 2.76 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 485,108 | 2.9M $ | 0.00 % | 1.02 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 269,435 | 1.7M $ | 0.06 % | 0.56 % | as of Apr 30, 2026 ↗ |
| Federated Hermes Kaufmann Fund Federated Hermes Equity Funds | 225,722 | 1.5M $ | 0.03 % | 0.47 % | as of Apr 30, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 31,000 | 200.6K $ | 0.00 % | 0.06 % | as of Apr 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 23,025 | 138.7K $ | 0.00 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 19,845 | 131K $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 18,555 | 111.8K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 17,256 | 113.9K $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Federated Hermes Kaufmann Fund II Federated Hermes Insurance Series | 13,567 | 81.7K $ | 0.09 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 9,045 | 59.7K $ | 0.00 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 6,737 | 44.5K $ | 0.01 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Federated Hermes Kaufmann Fund II Federated Hermes Insurance Series | 0.09 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 0.06 % | as of Apr 30, 2026 ↗ |
| Federated Hermes Kaufmann Fund Federated Hermes Equity Funds | 0.03 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 12 | +3 | 2,438,438 | +64.5 % |
| 2026Q1 | 9 | 0 | 1,482,124 | -0.6 % |
| 2025Q4 | 9 | 0 | 1,491,627 | -1.8 % |
| 2025Q3 | 9 | 0 | 1,519,250 | +1.3 % |
| 2025Q2 | 9 | 0 | 1,500,298 | -0.1 % |
| 2025Q1 | 9 | 0 | 1,501,165 | +0.0 % |
| 2024Q4 | 9 | 0 | 1,500,810 | +0.1 % |
| 2024Q3 | 9 | -2 | 1,499,068 | -16.6 % |
| 2024Q2 | 11 | +1 | 1,796,492 | -7.6 % |
| 2024Q1 | 10 | -1 | 1,943,867 | -0.2 % |
| 2023Q4 | 11 | 1,947,471 |
Institutional managers
41 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| FEDERATED HERMES, INC. | 5,113,224 | 30.8M $ | as of Mar 31, 2026 |
| Vivo Capital, LLC | 4,322,747 | 26M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 4,294,259 | 25.9M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 4,258,600 | 25.7M $ | as of Mar 31, 2026 |
| Logos Global Management LP | 3,215,000 | 19.4M $ | as of Mar 31, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | 2,365,000 | 14.2M $ | as of Mar 31, 2026 |
| Foresite Capital Management VI LLC | 1,986,600 | 12M $ | as of Mar 31, 2026 |
| Ally Bridge Group (NY) LLC | 1,655,500 | 10M $ | as of Mar 31, 2026 |
| Spruce Street Capital LP | 1,655,500 | 10M $ | as of Mar 31, 2026 |
| Trails Edge Capital Partners, LP | 1,419,000 | 8.5M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,419,000 | 8.5M $ | as of Mar 31, 2026 |
| DV Trading LLC | 889,254 | 5.4M $ | as of Mar 31, 2026 |
| ACUTA CAPITAL PARTNERS, LLC | 709,500 | 4.3M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 708,291 | 4.3M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 624,857 | 3.8M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 338,735 | 2M $ | as of Mar 31, 2026 |
| Seven Fleet Capital Management LP | 248,476 | 1.5M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 218,759 | 1.3M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 119,131 | 717.8K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 93,308 | 562.2K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 89,700 | 540.4K $ | as of Mar 31, 2026 |
| UBS Group AG | 67,570 | 407.1K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 56,349 | 339.5K $ | as of Mar 31, 2026 |
| Apella Capital, LLC | 42,250 | 284.3K $ | as of Mar 31, 2026 |
| Brendel Financial Advisors LLC | 41,799 | 251.8K $ | as of Mar 31, 2026 |
Declared shareholders of Minerva Neurosciences Inc
2 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Balyasny Asset Management L.P. and 4 others | 9.99 % | 4,323,112 | as of Mar 31, 2026 · SCHEDULE 13G |
| JANUS HENDERSON GROUP PLC | 9.90 % | 4,307,759 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Minerva Neurosciences Inc". https://titelia.com/en/stocks/minerva-neurosciences-inc-US6033802058